Yves Paul Mbous, PhD

AbbVie, Inc.

Poster(s):

• 1412 - Real-world Utilization of Novel Therapies and Overall Survival among U.S. Medicare Beneficiaries Initiating Frontline Chronic Lymphocytic Leukemia Treatment